COMPANY

INTELLECTUAL PROPERTY

  • AAV vectors

    CNS-specific peptides & AAV variants

    • Registration

    • Application

      KOREA (July, 2024)

  • AAV vectors

    cell-specific peptides & AAV variants (4 ZPs filed)

    • Registration

    • Application

      Korea(February, 2024)

  • GXC-301

    Patent for the treatment of Lafora's disease

    • Registration

    • Application

      KOREA (July, 2023)

  • AAV Composition, etc

    Composition for AAV delivery and AAV delivery efficiency screening method

    • Registration

    • Application

      KOREA (June, 2023)

  • GXC - 101

    AD/PD/MCI therapeutic agent

    • Registration

      KOREA (December, 2017)
      USA (July, 2020)
      CHINA (June, 2021)

    • Application

      CHINA, PCT(Jun, 2016 )